Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504–11.
Article PubMed PubMed Central Google Scholar
Wang C, Liu J. Research progress of chronic Kidney Disease complicated with coronary artery Disease. Chin J Pract Int Med. 2006;03:229–31.
Baber U, Farkouh ME, Arbel Y, Muntner P, Dangas G, Mack MJ, et al. Comparative efficacy of coronary artery bypass Surgery vs. percutaneous coronary intervention in patients with Diabetes and multivessel coronary artery Disease with or without chronic Kidney Disease. Eur Heart J. 2016;37(46):3440–7.
Giustino G, Mehran R, Serruys PW, Sabik JF 3rd, Milojevic M, Simonton CA, et al. Left main revascularization with PCI or CABG in patients with chronic Kidney Disease: EXCEL trial. J Am Coll Cardiol. 2018;72(7):754–65.
Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation Myocardial Infarction: data from the Swedish web-system for enhancement and development of evidence-based care in Heart Disease evaluated according to recommended therapies (SWEDEHEART). Circulation. 2009;120(10):851–8.
Article CAS PubMed Google Scholar
Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, et al. Patients with severe chronic Kidney Disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013;168(4):3741–6.
Vuurmans T, Er L, Sirker A, Djurdjev O, Simkus G, Levin A. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic Kidney Disease: a propensity-matched cohort study. Coron Artery Dis. 2018;29(1):8–16.
Milojevic M, Head SJ, Mack MJ, Mohr FW, Morice MC, Dawkins KD, et al. The impact of chronic Kidney Disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery Disease: five-year follow-up of the SYNTAX trial. EuroIntervention. 2018;14(1):102–11.
Kang SH, Lee CW, Yun SC, Lee PH, Ahn JM, Park DW, et al. Coronary artery bypass grafting vs. drug-eluting stent implantation for Multivessel Disease in patients with chronic Kidney Disease. Korean Circ J. 2017;47(3):354–60.
Article PubMed PubMed Central Google Scholar
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435–534.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2019;140(11):e596–e646.
PubMed PubMed Central Google Scholar
Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, et al. Trial of everolimus-eluting stents or bypass Surgery for coronary Disease. N Engl J Med. 2015;372(13):1204–12.
Article CAS PubMed Google Scholar
Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in patients with Multivessel Coronary Artery Disease and chronic Kidney Disease: Everolimus-Eluting stents Versus Coronary artery bypass graft Surgery. J Am Coll Cardiol. 2015;66(11):1209–20.
Article PubMed PubMed Central Google Scholar
Nagendrababu V, Dilokthornsakul P, Jinatongthai P, Veettil SK, Pulikkotil SJ, Duncan HF, et al. Glossary for systematic reviews and meta-analyses. Int Endod J. 2020;53(2):232–49.
Article CAS PubMed Google Scholar
Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Fourth universal definition of myocardial infarction. (2018). Rev Esp Cardiol (Engl Ed). 2019;72(1):72.
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Article PubMed PubMed Central Google Scholar
Lima EG, Charytan DM, Hueb W, de Azevedo DFC, Garzillo CL, Favarato D, et al. Long-term outcomes of patients with stable coronary Disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery study II trial. Nephrol Dial Transplant. 2020;35(8):1369–76.
Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, et al. Association of chronic Kidney Disease with clinical outcomes after coronary revascularization: the arterial revascularization therapies study (ARTS). Am Heart J. 2005;149(3):512–9.
Aoki J, Ong AT, Hoye A, van Herwerden LA, Sousa JE, Jatene A, et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery Disease: insights from ARTS trial. Eur Heart J. 2005;26(15):1488–93.
Wu P, Luo F, Fang Z. Multivessel Coronary revascularization strategies in patients with chronic Kidney Disease: a Meta-analysis. Cardiorenal Med. 2019;9(3):145–59.
Kumada Y, Ishii H, Aoyama T, Kamoi D, Kawamura Y, Sakakibara T, et al. Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients. Circ J. 2014;78(4):986–92.
Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein P, Falk V, et al. PCI and CABG for treating stable coronary artery Disease: JACC Review topic of the Week. J Am Coll Cardiol. 2019;73(8):964–76.
de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic Kidney Disease in the United States. JAMA. 2011;305(24):2532–9.
Article PubMed PubMed Central Google Scholar
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic Kidney Disease - A systematic review and Meta-analysis. PLoS ONE. 2016;11(7):e0158765.
Article PubMed PubMed Central Google Scholar
Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation Myocardial Infarction and chronic Kidney Disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4(9):1002–8.
Article PubMed PubMed Central Google Scholar
Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z. Risk prediction models for contrast induced Nephropathy: systematic review. BMJ. 2015;351:h4395.
Article PubMed PubMed Central Google Scholar
Zhang Z, Ni H, Xu X. Do the observational studies using propensity score analysis agree with randomized controlled trials in the area of sepsis? J Crit Care. 2014;29(5):886e9–15.
Comments (0)